Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.
Better Therapeutics Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
First prescription digital behavioral therapeutic device delivering novel form of cognitive behavioral therapy via smartphone
In a randomized controlled trial AspyreRx demonstrated clinically meaningful and statistically significant durable reductions in A1c
Company to host conference call and webcast on July 11 at 8:30 a.m. ET